Association of superoxide production by NAD(P)H oxidase with systaemic endothelial dysfunction in human blood vessels: relationship to clinical risk factors

Association of superoxide production by NAD(P)H oxidase with systaemic endothelial dysfunction in human blood vessels: relationship to clinical risk factors

Bibliographic Details
Main Authors:	Guzik, T, West, N, Black, E, McDonald, D, Ratnatunga, C, Pillai, R, Channon, K
Format:	Journal article
Published:	2000

Similar Items

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.
by: Guzik, T, et al.
Published: (2000)

Superoxide production by NAD(P)H oxidase in human blood vessels: Functional interaction with nitric oxide
by: Guzik, T, et al.
Published: (2000)

Relationship of NAD(P)H oxidase activity in human blood vessels to endothelial dysfunction and clinical risk factors
by: Guzik, T, et al.
Published: (2000)

UltraRapid communications : vascular superoxide production by NAD(P)H OxidaseAssociation with endothelial dysfunction and clinical risk factors
by: Guzik, T, et al.
Published: (2000)

Superoxide generation by NAD(P)H oxidase in human sphenous vein: Interaction with nitric oxide
by: Guzik, T, et al.
Published: (2000)

Functional impact of genetic polymorphisms in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis
by: Guzik, T, et al.
Published: (2000)

Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis.
by: Guzik, T, et al.
Published: (2000)

Functional importance of C242T polymorphism in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis
by: Guzik, T, et al.
Published: (2000)

Enhanced superoxide anion production in experimental venous bypass grafts is mediated by NAD(P)H oxidase
by: West, N, et al.
Published: (2000)

Vascular superoxide generation by NAD(P)H oxidase is increased in humans with type II diabetes mellitus
by: Guzik, T, et al.
Published: (2001)

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.
by: Guzik, T, et al.
Published: (2002)

Superoxide generation by NAD(P)H oxidases in human bypass graft vessels.
by: Guzik, T, et al.
Published: (2002)

Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
by: West, N, et al.
Published: (2001)

Systemic upregulation of vascular NAD(P)H oxidase in human atherosclerosis: Association with clinical risk factors.
by: Guzik, T, et al.
Published: (2000)

Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors.
by: Channon, K, et al.
Published: (2002)

Nitric oxide-superoxide interactions in human blood vessels: implications for vascular peroxynitrite formation
by: Guzik, T, et al.
Published: (2001)

Superoxide production by NAD(P)H oxidases in human bypass graft vessels - Role in the regulation of vascular tone
by: Guzik, T, et al.
Published: (2002)

Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels.
by: Guzik, T, et al.
Published: (2002)

Superoxide generation during cardiopulmonary bypass in conventional coronary artery bypass graft surgery: is there a role for myocardial NAD(P)H oxidase?
by: Kim, Y, et al.
Published: (2004)

Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis.
by: Guzik, T, et al.
Published: (2001)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation (AF)
by: Kim, Y, et al.
Published: (2003)

Direct improvement of endothelial function and superoxide production in human vessels, by oral folic acid treatment: A double blind placebo controlled study
by: Antoniades, C, et al.
Published: (2005)

Relationships of promoter and coding sequence genetic polymorphisms of p22phox subunit to the vascular NAD(P)H oxidase activity
by: Guzik, T, et al.
Published: (2004)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
by: Kim, Y, et al.
Published: (2005)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.
by: Kim, Y, et al.
Published: (2005)

5-methyl-tetrahydrofolate acid improves endothelial function and decreases superoxide production in vessels from patients with coronary artery disease
by: Antoniades, C, et al.
Published: (2006)

Endothelial dysfunction and increased vascular superoxide generation in the type II diabetic (Goto-Kakisaki) rat occur independently of plasma cholesterol levels
by: West, N, et al.
Published: (2000)

Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM.
by: Sachin Gupte, et al.
Published: (2010-07-01)

Chronic treatment with folic acid improves endothelial function and decreases superoxide production in human vessels. A double blind placebo control study
by: Shirodaria, C, et al.
Published: (2005)

Minimally invasive saphenous vein harvesting: effects on endothelial and smooth muscle function.
by: Black, E, et al.
Published: (2001)

Low- and high- dose treatment with folic acid, equally improve endothelial function and decrease superoxide production in human vessels via tetrahydrobiopterin-mediated eNOS coupling
by: Antoniades, C, et al.
Published: (2007)

Endothelial and smooth muscle function are preserved with minimally invasive saphenous vein harvest: A prospective randomised trial.
by: Black, E, et al.
Published: (2000)

5-Methyl-tetrahydrofolate acid improves endothelial function and decreases superoxide production by improving eNOS coupling and increasing tetrahydrobiopterin bioavailability in human vessels in vivo
by: Antoniades, C, et al.
Published: (2006)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after coronary artery bypass graft surgery
by: Kim, Y, et al.
Published: (2006)

5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling.
by: Antoniades, C, et al.
Published: (2006)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after on-pump coronary artery bypass graft surgery
by: Kim, Y, et al.
Published: (2005)

Modification of superoxide-nitric oxide interactions in experimental venous bypass graft pathobiology by NOS gene transfer
by: West, N, et al.
Published: (2001)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
by: Kim, Y, et al.
Published: (2005)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins
by: Guzik, T, et al.
Published: (2004)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.
by: Guzik, T, et al.
Published: (2004)